Peregrine Cancer Cure Technologies Private Limited - Company Profile

It is a veterinary private limited company based in Bangalore, Karnataka, India, established in 2017.
2017 Bangalore, Karnataka, India Struck Off
Last Updated:
Access Report
About Peregrine Cancer Cure Technologies Private Limited

Peregrine Cancer Cure Technologies Private Limited, a struck off private limited company, was established on 08 September 2017 in Bangalore, Karnataka, India. Engaging in animal health services within the veterinary sector, it holds CIN: U85200KA2017PTC106245. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.

It upholds a compliant status. Its leadership includes Soumya Rengarajan (Director), Balachander Agoramurthy (Director). Its latest AGM occurred on 30 September 2022, with the balance sheet filed on 31 March 2022. It is based at No.107, B Block, Aban Essence, 1St Floor S.No.60, Kudlu Village, Madiwala Post, Bangalore, Karnataka, 560068.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U85200KA2017PTC106245

  • Registration Number

    106245

  • Incorporation Date

    08 September 2017

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹1.00 M

  • ROC Code

    Roc Bangalore

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 1.00 M
  • Company Age 8 Year, 5 Months
  • Last Filing with ROC 31 Mar 2022
  • Revenue Growth **** %
  • Profit Growth **** -196.61%
  • Ebitda **** -127.50%
  • Net Worth -18.94%
  • Total Assets -24.38%
Company report

Peregrine Cancer Cure Technologies Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Peregrine Cancer Cure Technologies Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Peregrine Cancer Cure Technologies Private Limited?
Current Directors
Name Designation Appointment Date Status
Soumya Rengarajan Director 08 Sep 2017 Current
Balachander Agoramurthy Director 08 Sep 2017 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Peregrine Cancer Cure Technologies.

Peregrine Cancer Cure Technologies Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 196.61% decrease in profit. The company's net worth observed a substantial decline by a decrease of 18.94%.

Peregrine Cancer Cure Technologies revenue growth over time
Peregrine Cancer Cure Technologies profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
 -24.38%
*******
*******
*******
*******
Profit or Loss
*******
 -196.61%
*******
*******
*******
*******
Net Worth
*******
 -18.94%
*******
*******
*******
*******
EBITDA
*******
 -127.50%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Peregrine Cancer Cure Technologies?

Unlock access to Peregrine Cancer Cure Technologies's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Peregrine Cancer Cure Technologies?

Unlock and access historical data on people associated with Peregrine Cancer Cure Technologies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Peregrine Cancer Cure Technologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Peregrine Cancer Cure Technologies's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Peregrine Cancer Cure Technologies
Recent Activity within the Organization
  • Annual General Meeting

    Peregrine Cancer Cure Technologies Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Peregrine Cancer Cure Technologies Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Bangalore. was recorded as a recent event.

  • Director Appointment

    Progress on Soumya Rengarajan was appointed as a Director was appointed as a Director on 08 Sep 2017 & has been associated with this company since 8 years 5 months . was documented.

  • Director Appointment

    Progress on Balachander Agoramurthy was appointed as a Director was appointed as a Director on 08 Sep 2017 & has been associated with this company since 8 years 5 months . was documented.

  • Company Incorporation

    Peregrine Cancer Cure Technologies Private Limited was registered on 08 Sep 2017 with Roc Bangalore & aged 8 years 5 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Peregrine Cancer Cure Technologies Private Limited?

The CIN of Peregrine Cancer Cure Technologies Private Limited is U85200KA2017PTC106245.

Where is Peregrine Cancer Cure Technologies Private Limited headquartered?

Peregrine Cancer Cure Technologies Private Limited is headquartered at No.107, B Block, Aban Essence, 1St Floor S.No.60, Kudlu Village, Madiwala Post, Bangalore, Karnataka, 560068.

When was Peregrine Cancer Cure Technologies Private Limited incorporated?

Peregrine Cancer Cure Technologies Private Limited was incorporated on 08 September 2017.

Who are the current directors of Peregrine Cancer Cure Technologies Private Limited?

The current directors of Peregrine Cancer Cure Technologies Private Limited are

What is the primary industry of Peregrine Cancer Cure Technologies Private Limited?

The primary industry of Peregrine Cancer Cure Technologies Private Limited is Veterinary.

Is Peregrine Cancer Cure Technologies Private Limited a listed company?

Peregrine Cancer Cure Technologies Private Limited is unlisted.

What is the capital structure of Peregrine Cancer Cure Technologies Private Limited?

The authorized capital of Peregrine Cancer Cure Technologies Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.

What is the compliance status of Peregrine Cancer Cure Technologies Private Limited?

The compliance status of Peregrine Cancer Cure Technologies Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available